Related references
Note: Only part of the references are listed.
Article
Psychology, Clinical
Daniel Freeman et al.
Summary: Blood-injection-injury fears contribute to approximately 10% of COVID-19 vaccine hesitancy in the UK adult population. Addressing these fears can improve the effectiveness of vaccination programs.
PSYCHOLOGICAL MEDICINE
(2023)
Article
Psychology, Clinical
Robin C. Vanderpool et al.
Summary: Addressing vaccine hesitancy and improving vaccine uptake among cancer survivors is crucial due to their increased vulnerability to complications from COVID-19. Factors such as underrepresentation in vaccine trials and distinct recommendations for certain subgroups complicate efforts to increase vaccine confidence. Evidence suggests strategies considering social norms, risk perceptions, and trust can enhance vaccine communication targeting this population. However, more behavioral research is needed to better understand drivers of hesitancy and ensure optimal protection for this at-risk group, with potential implications for future vaccination efforts and communication with cancer survivors beyond the current pandemic.
JOURNAL OF BEHAVIORAL MEDICINE
(2023)
Article
Oncology
Nicci Bartley et al.
Summary: This study aimed to explore the perspectives of cancer stakeholders regarding COVID-19 vaccination. The findings revealed mostly positive attitudes towards the vaccine, but also highlighted concerns, hesitancy, and uncertainty. Policymakers need to provide clear tailored information to facilitate vaccine uptake.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
(2023)
Article
Behavioral Sciences
Lisa Grech et al.
Summary: This study developed a scale, DIVAS-6, to assess attitudes and concerns related to COVID-19 vaccination in individuals with underlying diseases. The scale was validated in patients with cancer, diabetes, and multiple sclerosis, showing good psychometric properties and convergent validity. DIVAS-6 can assist in guiding information delivery about COVID-19 vaccination in medically vulnerable populations.
BEHAVIORAL MEDICINE
(2023)
Article
Oncology
Mike Nguyen et al.
Summary: This study investigated the COVID-19 vaccine uptake and hesitancy among patients with solid organ and blood cancers. The results showed that a significant proportion of patients remained unvaccinated, despite being eligible for vaccination. Vaccine uptake was associated with factors such as age, gender, language, time since cancer diagnosis, and current anticancer treatment. Concerns about side effects and the desire for medical advice were prominent among unvaccinated patients.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
(2022)
Article
Public, Environmental & Occupational Health
Jessica Kaufman et al.
Summary: Tailored communication is essential in addressing COVID-19 vaccine hesitancy and increasing uptake, especially among prioritised adults and healthcare workers. The study identified specific safety concerns and perceived benefits of vaccination among the hesitant population, highlighting the need for improved information and guidance in promoting vaccine acceptance.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH
(2022)
Article
Psychology, Clinical
Daniel Freeman et al.
Summary: The study aimed to estimate the willingness to receive a COVID-19 vaccine, identify predictive socio-demographic factors, and determine potential causes in order to provide guidance on information provision. The findings showed that willingness to take the vaccine is closely linked to recognition of its collective importance, and factors such as conspiracy beliefs lower vaccine uptake. Socio-demographic factors such as age, gender, income, and ethnicity also played a role in vaccine hesitancy.
PSYCHOLOGICAL MEDICINE
(2022)
Article
Oncology
Vivek Naranbhai et al.
Summary: The study investigated the immune responses to SARS-CoV-2 vaccines in cancer patients, showing that the vaccine-induced immune responses were quantitatively lower in cancer patients compared to healthy controls, recommending antibody testing to identify those who may benefit from additional vaccine doses.
JOURNAL OF CLINICAL ONCOLOGY
(2022)
Letter
Oncology
Yakir Rottenberg et al.
Article
Public, Environmental & Occupational Health
Richard Tsai et al.
Summary: This study investigated COVID-19 vaccine hesitancy and acceptance among individuals with comorbid conditions. Significant vaccine hesitancy was found, and early self-reported side effect experiences among those who had already been vaccinated may help alleviate vaccine fears. Health care-related social media forums may play an important role in disseminating accurate information about COVID-19 vaccines.
JMIR PUBLIC HEALTH AND SURVEILLANCE
(2022)
Article
Oncology
Nesrine Mejri et al.
Summary: The study found that factors like educational level, history of comorbidities, history of influenza vaccination, and patient's opinion about COVID-19 severity did not predict vaccine resistance. However, patients who thought the vaccine may interfere with treatment efficacy or cancer outcome were more likely to refuse the vaccine. Patients who disagreed that the vaccine is a major weapon against the pandemic or could reduce virus transmission were also more likely to reject vaccination. Safety concerns and confidence in authorities were also significant predictive factors.
SUPPORTIVE CARE IN CANCER
(2022)
Review
Medicine, General & Internal
Ainsley Ryan Yan Bin Lee et al.
Summary: This systematic review and meta-analysis compared the efficacy of covid-19 vaccines between immunocompromised and immunocompetent individuals. The results showed that immunocompromised patients, especially organ transplant recipients, had significantly lower rates of seroconversion after covid-19 vaccination. A second dose of the vaccine consistently improved seroconversion in all patient groups, although the improvement was smaller for organ transplant recipients. Targeted interventions, including a third dose (booster) of the vaccine, should be performed for immunocompromised patients.
BMJ-BRITISH MEDICAL JOURNAL
(2022)
Article
Immunology
Daphne Day et al.
Summary: This study investigated vaccine uptake and hesitancy among individuals with serious and/or chronic health conditions, and found that unvaccinated individuals were more likely to be younger, female, have lower education and income, speak English as a second language, and reside in regional areas. Unvaccinated participants reported greater vaccine hesitancy and more negative perceptions toward vaccines. Disease-related vaccine concerns were associated with unvaccinated status and hesitancy.
Review
Medicine, General & Internal
Emma Khoury et al.
Summary: The study found that patients with cancer and SARS-CoV-2 infection had a higher risk of death compared to those without cancer. Younger age, lung cancer, and hematologic cancer were identified as risk factors associated with poor outcomes from COVID-19.
Article
Oncology
Rocco Servidio et al.
Summary: This study aims to examine the predictors of cancer patients' intentions and behaviors regarding COVID-19 vaccination. It found that trust in health authorities, subjective norms, and attitudes towards vaccines play significant roles in vaccination intentions. Additionally, perceived risk is associated with subjective norms but not with perceived behavioral control or attitudes. The findings highlight the importance of enhancing trust in health authorities and promoting vaccine-positive subjective norms for effective vaccination campaigns.
SUPPORTIVE CARE IN CANCER
(2022)
Article
Medicine, General & Internal
Merryn Voysey et al.
Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.
Letter
Medicine, General & Internal
Amy Body et al.
INTERNAL MEDICINE JOURNAL
(2021)
Article
Public, Environmental & Occupational Health
Kathleen Dooling et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
(2021)
Article
Biochemistry & Molecular Biology
Rachna T. Shroff et al.
Summary: Cancer patients showed diminished immune responses to the BNT162b2 mRNA vaccine compared to the control group, but a third dose of the vaccine was found to be safe and significantly improved humoral immunity against SARS-CoV-2.
Review
Public, Environmental & Occupational Health
G. Troiano et al.
Summary: During the COVID-19 pandemic, vaccine hesitancy remains a significant issue, with factors such as ethnicity, working status, religiosity, politics, gender, age, education, and income influencing acceptance or refusal. Common reasons for vaccine refusal include concerns about safety, belief in the vaccine's ineffectiveness, lack of trust, doubts about vaccine efficiency, belief in preexisting immunity, and skepticism about the vaccine's origins.
Article
Biotechnology & Applied Microbiology
Weitao Zhuang et al.
Summary: The study shows that patient misconception significantly contributes to vaccine hesitancy, indicating the necessity for evidence-based education tailored to specific concerns.
HUMAN VACCINES & IMMUNOTHERAPEUTICS
(2021)
Letter
Oncology
J. Barriere et al.
ANNALS OF ONCOLOGY
(2021)
Review
Immunology
Kimberly R. Nehal et al.
Summary: Global willingness to vaccinate against COVID-19 is estimated at 66.01%, but varies between countries and regions. Vaccine acceptance or refusal is significantly associated with factors such as age, gender, education, attitudes, and perceptions about vaccines.
Article
Public, Environmental & Occupational Health
Daniel Freeman et al.
Summary: The study aimed to test which types of written information about COVID-19 vaccination might increase vaccine acceptance. Personal benefit information reduced hesitancy in strongly hesitant individuals more than information on collective benefits, demonstrating the importance of addressing individual concerns in vaccine messaging.
LANCET PUBLIC HEALTH
(2021)
Article
Immunology
Anna Brodziak et al.
Summary: Most Polish cancer patients have a positive attitude towards COVID-19 vaccination, but express concerns about safety, effectiveness, and the development process of the vaccine. Key factors influencing willingness to vaccinate include education level, marital status, and positive attitude towards vaccinations.
Review
Immunology
Majdi M. Sabahelzain et al.
Summary: Amid the emergence of COVID-19 virus variants, vaccine nationalism trends, and multiple vaccine supply challenges, uncertainties and challenges related to COVID-19 vaccination persist. Public confidence in new COVID-19 vaccines varies greatly, with minority communities showing less trust in both the vaccines themselves and the entities involved in their production and distribution. How governments handle the COVID-19 response will play a crucial role in shaping public confidence in and acceptance of COVID vaccination.
CURRENT OPINION IN IMMUNOLOGY
(2021)
Article
Oncology
Luigi Cavanna et al.
Summary: The study showed that vaccination with BNT162b2 or mRNA-1273 vaccines was safe and effective in adult patients with solid cancer, with a 75.88% seropositivity rate among patients. No Grade 3-4 side-effects or COVID-19 infections were reported, indicating good safety and immunogenicity of the vaccines in this population.
EUROPEAN JOURNAL OF CANCER
(2021)
Article
Medicine, General & Internal
Yada Kanjanapan et al.
Summary: The vulnerable population of people with cancer are at higher risk for adverse outcomes from COVID-19, making vaccination key in protecting them from SARS-CoV-2 infection. The Medical Oncology Group of Australia addressed the safety and efficacy considerations around COVID-19 vaccination in cancer patients, including evaluating allergic reactions and implementing vaccination for those on active anti-cancer therapy.
INTERNAL MEDICINE JOURNAL
(2021)
Meeting Abstract
Oncology
Paris A. Kosmidis et al.
JOURNAL OF CLINICAL ONCOLOGY
(2021)
Meeting Abstract
Oncology
Andrea Dwyer et al.
JOURNAL OF CLINICAL ONCOLOGY
(2021)
Editorial Material
Medicine, General & Internal
David A. Henry et al.
Summary: Community-based studies in five countries consistently show strong benefits from early rollouts of COVID-19 vaccines.
MEDICAL JOURNAL OF AUSTRALIA
(2021)
Letter
Oncology
Cynthia Villarreal-Garza et al.
Article
Oncology
June Young Chun et al.
Summary: Despite the importance of COVID-19 vaccination in cancer patients, overall vaccine uptake rates are low. Factors such as disease status, health status, and physician recommendations were found to be associated with higher acceptance rates of vaccination. Physicians play a crucial role in influencing cancer patients' decisions regarding COVID-19 vaccines.
Article
Oncology
Alfred Chung Pui So et al.
Summary: This study investigated the safety of COVID-19 vaccines in cancer patients at a center in London, finding that these patients generally tolerated the vaccines well with mild reactogenicity, experiencing common side effects such as sore arm, fatigue, and headaches. The results suggest that COVID-19 vaccines could be a feasible option for oncology patients, allowing for a return to pre-pandemic oncology care.
Article
Immunology
McClaren Rodriguez et al.
Summary: Ethnic minority populations are more likely to suffer from chronic comorbidities, which increase their vulnerability to poor health outcomes associated with COVID-19 infection. This study found that individuals self-reporting cancer and chronic conditions were more likely to perceive higher susceptibility and severity of COVID-19, and were more willing to get vaccinated compared to healthy individuals.
Article
Oncology
Vincenzo Di Noia et al.
Summary: This study reported on the compliance with COVID-19 vaccination among patients affected by solid tumors, revealing concerns about vaccine-related adverse events, negative interactions with concomitant antitumor therapy, and fear of allergic reactions as common reasons for refusal. Additionally, the refusal rate more than doubled after the suspension of AstraZeneca-AZD1222, indicating the impact of regulatory decisions and media news on vaccination campaigns.
EUROPEAN JOURNAL OF CANCER
(2021)
Article
Health Care Sciences & Services
Amar H. Kelkar et al.
Summary: Clinical oncologists can influence cancer patients' attitudes towards COVID-19 vaccination, and positive communication about vaccines can increase enthusiasm for vaccination.
Editorial Material
Oncology
Wenhua Liang et al.
Article
Public, Environmental & Occupational Health
Steven Lloyd Wilson et al.
Article
Immunology
Noni E. MacDonald
